Therefore, utilizing the mechanisms identified here that underlie the beneficial effect of these metabolites and P-gp induction in the local context of the intestine can be regarded as a potential therapeutic opportunity in ulcerative colitis and other inflammatory conditions of the intestine. The gene discussed is PGP; the disease is ulcerative colitis.